{
    "code": "02021628",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021628",
    "time": "2019-06-28 03:35:08",
    "許可證字號": "衛署藥輸字第021628號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/04\/09",
    "發證日期": "86\/04\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202162804",
    "中文品名": "柯寧優尼點眼懸液",
    "英文品名": "KARY UNI OPHTHALMIC SUSPENSION",
    "適應症": "初期老人性白內障。",
    "劑型": "483點眼懸液劑",
    "包裝": "100公撮以下瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "PIRFENOXONE (eq to CATALIN)( eq to PIRENOXINE)",
    "主製造廠": {
        "申請商名稱": "1433601100  台灣參天製藥股份有限公司",
        "申請商地址": "台北市中山區松江路126號9樓之1",
        "主製造廠": "",
        "製造廠名稱": "FJP0270000  SANTEN PHARMACEUTICAL CO. LTD.(NOTO PLANT)"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5236000100",
            "成分名稱": "PIRFENOXONE (eq to CATALIN)( eq to PIRENOXINE)",
            "含量描述": "",
            "含量": "0.0500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020216280001-106-02-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021628&Seq=005&Type=9"
        },
        {
            "title": "020216280002-105-11-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021628&Seq=006&Type=8"
        }
    ]
}